Lessons from past experience in cancer immutiotherapy and their application to cancer and AIDS treatment and prophylaxis
- 31 December 1989
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 43 (8) , 551-561
- https://doi.org/10.1016/0753-3322(89)90032-2
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- IL-2: a review of current knowledgeCancer Treatment Reviews, 1989
- Augmentation of Human Cytotoxic T Lymphocytes against Autologous Tumor by a Factor Released from Human Monocytic Leukemia Cell LineJapanese Journal of Cancer Research, 1989
- ADJUVANT THERAPY BY BCG OF NON‐HODGKIN'S MALIGNANT LYMPHOMAS IN A CONTROLLED TRIAL: AN UPDATEBritish Journal of Haematology, 1989
- Monoclonal antibody against tumour‐derived cell line shows heterogeneity of altered hepatocytes during afb1‐induced carcinogenesisInternational Journal of Cancer, 1984
- Die operative Behandlung des ZervixkarzinomsGeburtshilfe und Frauenheilkunde, 1984
- Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes.The Journal of Experimental Medicine, 1980
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- Les divers aspects du syndrome secondaire compliquant les transfusions allogéniques de moelle osseuse ou de leucocytes chez des sujets atteints d'hémopathies malignesEuropean Journal of Cancer (1965), 1965
- Haematopoietic Chimera in Man After Allogenic (Homologous) Bone-marrow TransplantationBMJ, 1963